Ionis Pharmaceuticals Inc (IONS)
34.74
+0.80
(+2.36%)
USD |
NASDAQ |
Nov 22, 11:58
Ionis Pharmaceuticals Total Return Level: 33.94 for Nov. 21, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 21, 2024 | 33.94 |
November 20, 2024 | 35.40 |
November 19, 2024 | 33.75 |
November 18, 2024 | 33.73 |
November 15, 2024 | 34.34 |
November 14, 2024 | 37.23 |
November 13, 2024 | 37.78 |
November 12, 2024 | 37.77 |
November 11, 2024 | 38.88 |
November 08, 2024 | 39.19 |
November 07, 2024 | 38.46 |
November 06, 2024 | 39.04 |
November 05, 2024 | 38.80 |
November 04, 2024 | 38.44 |
November 01, 2024 | 38.76 |
October 31, 2024 | 38.39 |
October 30, 2024 | 39.26 |
October 29, 2024 | 39.71 |
October 28, 2024 | 40.36 |
October 25, 2024 | 39.19 |
October 24, 2024 | 38.77 |
October 23, 2024 | 38.42 |
October 22, 2024 | 38.68 |
October 21, 2024 | 39.00 |
October 18, 2024 | 39.68 |
Date | Value |
---|---|
October 17, 2024 | 38.49 |
October 16, 2024 | 39.16 |
October 15, 2024 | 37.84 |
October 14, 2024 | 38.63 |
October 11, 2024 | 38.44 |
October 10, 2024 | 37.95 |
October 09, 2024 | 38.06 |
October 08, 2024 | 37.80 |
October 07, 2024 | 37.86 |
October 04, 2024 | 37.91 |
October 03, 2024 | 37.81 |
October 02, 2024 | 39.38 |
October 01, 2024 | 39.07 |
September 30, 2024 | 40.06 |
September 27, 2024 | 40.85 |
September 26, 2024 | 41.10 |
September 25, 2024 | 40.99 |
September 24, 2024 | 41.00 |
September 23, 2024 | 41.83 |
September 20, 2024 | 42.76 |
September 19, 2024 | 42.74 |
September 18, 2024 | 42.36 |
September 17, 2024 | 41.51 |
September 16, 2024 | 40.70 |
September 13, 2024 | 42.19 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
25.61
Minimum
Dec 01 2021
65.27
Maximum
Dec 16 2019
44.19
Average
42.46
Median
Total Return Level Benchmarks
Biogen Inc | 158.01 |
Alnylam Pharmaceuticals Inc | 246.80 |
Biomarin Pharmaceutical Inc | 63.45 |
Amicus Therapeutics Inc | 9.50 |
Arbutus Biopharma Corp | 3.46 |